George M Jenkins sold $4.2M of PVLA
director at PALVELLA THERAPEUTICS, INC.. 27,500 shares at an average of $151.53, traded Sep 11, 2026, filed Sep 15, 2026.
Score components
- +15RoleDirector
- +25Trade size$4.2M at market
- +5Share of holdings soldSold 15% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-108022, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | SOpen-market sale Common Stock10b5-1 | -6,520 | $150.62 | $982k | 181,096 | 27 d ago |
| Sep 11, 2026 | SOpen-market sale Common Stock10b5-1 | -4,577 | $151.72 | $694k | 176,519 | 27 d ago |
| Sep 11, 2026 | SOpen-market sale Common Stock10b5-1 | -1,274 | $153.06 | $195k | 175,245 | 27 d ago |
| Sep 14, 2026 | SOpen-market sale Common Stock10b5-1 | -5,632 | $151.46 | $853k | 169,613 | 27 d ago |
| Sep 14, 2026 | SOpen-market sale Common Stock10b5-1 | -6,160 | $152.12 | $937k | 163,453 | 27 d ago |
| Sep 14, 2026 | SOpen-market sale Common Stock10b5-1 | -1,560 | $153.10 | $239k | 161,893 | 27 d ago |
| Sep 15, 2026 | SOpen-market sale Common Stock10b5-1 | -954 | $149.38 | $143k | 160,939 | 27 d ago |
| Sep 15, 2026 | SOpen-market sale Common Stock10b5-1 | -263 | $150.40 | $40k | 160,676 | 27 d ago |
| Sep 15, 2026 | SOpen-market sale Common Stock10b5-1 | -560 | $151.33 | $85k | 160,116 | 27 d ago |
Related signals
Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 42Moderate | PALVELLA THERAPEUTICS, INC. | Christopher P Kiritsy director | $49k 313 shares | -56% | |
| 21Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $415k 4,302 shares | -100% | |
| 20Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $371k 4,302 shares | -100% | |
| 29Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $101k 4,990 shares | +3% | |
| 22Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $52k 4,000 shares | +2% | |
| 23Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | James A Geraghty director | $1 1 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.